Literature DB >> 1723736

A study of the effect of chemical inactivants on the epitopes of Rift Valley fever virus glycoproteins using monoclonal antibodies.

N K Blackburn1, T G Besselaar.   

Abstract

A panel of 23 monoclonal antibodies (mAbs) was used to study the effect of formalin, beta propriolactone (BPL) and binary ethylenimine (BEI) on the epitopes of the Rift Valley fever virus glycoproteins. After the initial inactivation period BEI had very little adverse affect on the epitopes whereas BPL significantly altered seven and formalin partially changed the conformation or accessibility of most of the epitopes. The epitopes of all of the inactivated antigens showed a reduced activity against the specific mAbs over a six month storage period.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1723736     DOI: 10.1016/0166-0934(91)90036-y

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  13 in total

1.  Comparison of two different methods for inactivation of viruses in serum.

Authors:  T Preuss; S Kamstrup; N C Kyvsgaard; P Nansen; A Miller; J C Lei
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

2.  Chemical-free inactivated whole influenza virus vaccine prepared by ultrashort pulsed laser treatment.

Authors:  Shaw-Wei David Tsen; Nisha Donthi; Victor La; Wen-Han Hsieh; Yen-Der Li; Jayne Knoff; Alexander Chen; Tzyy-Choou Wu; Chien-Fu Hung; Samuel Achilefu; Kong-Thon Tsen
Journal:  J Biomed Opt       Date:  2015-05       Impact factor: 3.170

3.  Development and characterization of monoclonal antibodies against Rift Valley fever virus nucleocapsid protein generated by DNA immunization.

Authors:  Raquel Martín-Folgar; Gema Lorenzo; Hani Boshra; Javier Iglesias; Francisco Mateos; Belén Borrego; Alejandro Brun
Journal:  MAbs       Date:  2010-05-02       Impact factor: 5.857

4.  Activity of antibodies against Salmonella dublin, Toxoplasma gondii, or Actinobacillus pleuropneumoniae in sera after treatment with electron beam irradiation or binary ethylenimine.

Authors:  N C Kyvsgaard; P Lind; T Preuss; S Kamstrup; J C Lei; H O Bøgh; P Nansen
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

5.  Immunogenicity of formaldehyde and binary ethylenimine inactivated infectious bursal disease virus in broiler chicks.

Authors:  Mudasser Habib; Iftikhar Hussain; Hamid Irshad; Zong-zhao Yang; Jiang-bing Shuai; Ning Chen
Journal:  J Zhejiang Univ Sci B       Date:  2006-08       Impact factor: 3.066

6.  Inactivation of infectious bursal disease virus by binary ethylenimine and formalin.

Authors:  M Habib; I Hussain; W H Fang; Z I Rajput; Z Z Yang; H Irshad
Journal:  J Zhejiang Univ Sci B       Date:  2006-04       Impact factor: 3.066

7.  Effect of formaldehyde inactivation on poliovirus.

Authors:  Thomas Wilton; Glynis Dunn; David Eastwood; Philip D Minor; Javier Martin
Journal:  J Virol       Date:  2014-08-06       Impact factor: 5.103

8.  Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity.

Authors:  Natalija Budimir; Anke Huckriede; Tjarko Meijerhof; Louis Boon; Emma Gostick; David A Price; Jan Wilschut; Aalzen de Haan
Journal:  PLoS One       Date:  2012-01-27       Impact factor: 3.240

9.  Ebolavirus nucleoprotein C-termini potently attract single domain antibodies enabling monoclonal affinity reagent sandwich assay (MARSA) formulation.

Authors:  Laura J Sherwood; Andrew Hayhurst
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

10.  An effective inactivant based on singlet oxygen-mediated lipid oxidation implicates a new paradigm for broad-spectrum antivirals.

Authors:  Lei Zeng; Meng-Di Wang; Sheng-Li Ming; Guo-Li Li; Peng-Wei Yu; Yan-Li Qi; Da-Wei Jiang; Guo-Yu Yang; Jiang Wang; Bei-Bei Chu
Journal:  Redox Biol       Date:  2020-06-08       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.